Synovics Pharmaceuticals, Inc. (SYVC)
SYVC Stock Price Chart
Explore Synovics Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze SYVC price movements and trends.
SYVC Company Profile
Discover essential business fundamentals and corporate details for Synovics Pharmaceuticals, Inc. (SYVC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Jun 2023
Employees
155.00
CEO
John R. Palmer
Description
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
SYVC Financial Timeline
Browse a chronological timeline of Synovics Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
SYVC Stock Performance
Access detailed SYVC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.